author-photo

A Brioli

University of Bologna

12

Papers

58

Citations

Citation Trend

Filter By

Papers (7) Sort By

Journal Conference Others

Treatment of Transplant Eligible Patients with Multiple Myeloma

2018
Show All
- Source
- Cite
- Save
Citations (0)
Abstract 1521: High-throughput molecular profiling of Multiple Myeloma clonotypic CD19+ B cells highlights pathways potentially involved in the disease endurance

2015 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Bortezomib-thalidomide-dexamethasone (VTD) is superior to bortezomib-cyclophosphamide-dexamethasone (VCD) as induction therapy prior to autologous stem cell transplantation in multiple myeloma

2015 Leukemia
Show All
- Source
- Cite
- Save
Citations (47)
Long-term follow-up after autologous stem cell transplantation for light- and heavy-chain deposition disease

2012 Bone Marrow Transplantation
Show All
- Source
- Cite
- Save
Citations (6)
FDG PET/CT in multiple myeloma patients: Is it prognostic?

2011
Show All
- Source
- Cite
- Save
Citations (0)
Prognostic impact of cytogenetic abnormalities in newly diagnosed multiple myeloma patients treated with thalidomide-dexamethasone incorporated into double autologous stem-cell transplantation: A prospective analysis of 593 patients

2010 F1000Research
Show All
- Source
- Cite
- Save
Citations (0)
Bortezomib-Thalidomide-Dexamethasone as Primary Induction Therapy for Newly Diagnosed Multiple Myeloma Significantly Decreases Bone Resorption While Sparing Bone Formation as Compared to Thalidomide-Dexamethasone

2008 Blood
Show All
- Source
- Cite
- Save
Citations (1)